OR Kaitlyn Kelley

Welcome to the Division of Surgical Oncology

The Division of Surgical Oncology is at the forefront of treatment for patients with breast, GI stromal tumor, hepatobiliary-pancreatic, and peritoneal malignancies. Our faculty are active in basic and clinical research, funded by the National Institutes of Health/National Cancer Institute, the Veteran's Administration, and Stand Up to Cancer, among others. Most of these studies use molecularly targeted or other novel therapeutics not offered anywhere else in the nation.

Spotlight

Dr. Jula Veerapong

Welcome Dr. Jula Veerapong

Dr. Jula Veerapong, MD, Associate Clinical Professor of Surgery, who joined the Division in July 2017, specializes in HIPEC—heated intraperitoneal chemoperfusion—a procedure used to treat advanced abdominal cancers. Dr. Veerapong is also a champion for improving quality and will lead out enhanced post-operative recovery care program. Dr. Veerapong completed a surgical oncology fellowship at The University of Texas MD Anderson Cancer Center in Houston and a residency in general surgery at the University of Chicago Medical Center. Learn More


Recent Grants

Jason Sicklick, MD
Targeting Traditional Tumor Cells and Untraditional Tumor Microenvironment Cells in PDGFRA D842V GISTs
Funder: The David Foundation

Michael Bouvet, MD
Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers
Funder: NIH

Andrew M. Lowy, MD
RON receptor in pancreatic cancer biology and therapy
Funder: NIH

Jason Sicklick, MD
Targeting Imatinib-Resistant, KIT Negative Cells in Human GISTs
Funder: Kristen Ann Carr Fund

Rebekah White, MD
Irreversible electroporation as an in situ vaccine for pancreatic cancer
Funder: Salk Institute Cancer Center